Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 2Rectal Neoplasms 1Hand-Foot Syndrome 1Colonic Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Fluorouracil 3Cyclophosphamide 3pegfilgrastim 2Paclitaxel 2Immunoenzyme Techniques 2Epirubicin 2Chemotherapy, Adjuvant 2Biopsy 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 2orantinib 1eribulin 1Zoledronic Acid 1Therapeutics 1Taxes 1Sorafenib 1Radiotherapy 1Radioimmunodetection 1Pyridoxine 1Psychiatric Rehabilitation 1Neoadjuvant Therapy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunologic Techniques 1Ibandronic Acid 1Gene Rearrangement 1Gene Expression Profiling 1Flow Cytometry 1Drug Screening Assays, Antitumor 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms, Male × Pyridoxine × Clear all
NCT00559858 2013-08-02

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
270 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡